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Summary
Glucocorticoid receptors are ligand-activated transcription factors, which play an important 
role in the brain, mainly in stress response regulation. There are two types of receptors for 
glucocorticosteroids: mineralocorticoid receptors (MR) with high-affinity for the ligands and 
glucocorticoid receptors (GR) with a tenfold lower affinity. Selective activation of the receptors 
during hypoxia may decide neuronal fate, especially in the hippocampus. Depending on the 
severity of hypoxia-induced damage, neurons undergo necrosis or apoptosis. In the penumbral 
region, where neurons die mainly through the process of apoptosis, selective GR activation 
increases excitotoxicity, interferes with apoptotic signalling pathways and causes energy de-
ficit in the cells, all of which promote cell death. On the other hand, selective MR activation 
seems to be neuroprotective. It is suggested that the main role of MR in neuroprotection is to 
regulate the balance between anti- and proapoptotic proteins from bcl-2 family.
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INTRODUCTION
Glucocorticoid receptors are the receptors for steroid 
hormones synthesized in the adrenal cortex: glucocor-
ticosteroids (glucocorticoid receptors, GR or, according 
to other nomenclature, NR3C1) and mineralocorticoids 
(mineralocorticoid receptor, MR; NR3C2). Depending on 
the concentrations of the common of these receptors 
(cortisol in humans and corticosterone in rodents) dif-
ferent processes occur in neuronal cells, especially those 
of the hippocampus. MR activation improves neuronal 
survival and stimulates proliferation, whereas the acti-
vation of GR results in increased neurodegenerative pro-
cesses [42, 65, 70].
The brain is particularly vulnerable to homeostatic 
disturbances, including oxygen deficiency. In the core 
hypoxic zone, neurons die mainly via uncontrolled 
necrotic death, while in the, so called, penumbral area 
many cells die through apoptosis, which is a highly con-
trolled process. After hypoxia, the damage to the tis-
sues is mainly concentrated in the hippocampus, which 
has far-reaching consequences for the whole organism, 
due to the pivotal role of this structure in the stress 
response modulation or in the formation of memory 
traces. Anoxia/ischemia in the hippocampus upregu-
lates the expression of both types of glucocorticoid 
receptors MR and GR  [31, 45]. They regulate cellular 
response mainly through direct activation or suppres-
sion of target genes. However, the final result of MR 
and GR activity depends heavily on cell’s states, which 
is affected by such signalling substances as neurotrans-
mitters, hormones or cytokines [13]. More importantly, 
the synthesis or release of these substances, as well as 
concentrations and affinity of their receptors undergo 
significant changes in hypoxic conditions [54, 66]. 
High density of glucocorticoid receptors (GR) seems to 
be one of the underlying causes of the vulnerability to 
hypoxia/ischemia. Their activation in hypoxic condi-
tions is an important element of the cascade leading to 
neuronal death. However, in the penumbral area, the 
increase in the concentration of MR mRNA has been 
observed. This may indicate the development of an 
adaptive neuroprotective response based on MR activ-
ity [65]. Hypoxia constitutes a great threat for the life 
and health of endothermic vertebrates, starting with 
the fetal period. The pathophysiology of hypoxia is mul-
tilayered and conditions leading to hypoxia, mainly as 
a result of ischaemic and haemorrhagic strokes, vary. In 
contrast to most diseases, hypoxia is a sudden, unpre-
dictable event, often unnoticeable with delayed damag-
ing effects. The cells which die subsequently to hypoxia 
in the process of necrosis are impossible to save, but the 
extended in time (for about one week) apoptotic death 
provides a hope for significant decrease of the damage. 
The article covers the mechanisms underlying the 
bidirectional activity of glucocorticoid and miner-
alocorticoid receptors: on one hand, being one of 
the main elements of pathological processes during 
hypoxia (GR) and, on the other hand, promoting neu-
roprotection (MR).
GLUCOCORTICOID (GR) AND MINERALOCORTICOID (MR) 
RECEPTORS STRUCTURE 
Glucocorticoid receptors belong to the family of nuclear 
receptors (NR). Nuclear receptors are ligand-dependent 
transcription factors, which regulate a variety of intra-
cellular processes [46]. 48 NR-coding genes have been 
identified in the human genome. However, the number 
of receptor types is greater, because of many splicing-
related alternative protein isoforms [64]. Nearly half of 
the human NR are classified as orphan receptors, whose 
endogenous ligand have not been identified yet [20].
A two-stage model of NR activity was proposed in 
1967: (I) upon hormone binding the receptor is acti-
vated and (II) as a transcription factor binds to a spe-
cific DNA fragment, regulating genes. Ten years later, 
genes of 17 beta-estradiol and glucocorticoid recep-
tors were cloned, and they became the first known 
transcription factors [11].
All the NR, regardless of the kind of ligand they bind, dis-
play a homologous structure and comprise of 5 domains: 
A/B, C, D, E, F [30]. N-terminal A/B domain exhibits the 
biggest diversity in the NR family, and it contains frag-
ments that bind regulatory proteins responsible for 
tissue-specific action of receptors. The A/B domain con-
tains AF-1 fragment, which is thought to be a ligand-
independent transcriptional activator. AF-1 activating 
potential is much lower than that of the ligand-depend-
ent AF-2 fragment, which is located in the E domain. The 
role of N-terminal AF-1 fragment has not been fully elu-
cidated. Structural studies suggest that it may bind addi-
tional transcription factors and contribute significantly 
to allosteric regulation of the receptors [39, 41]. DNA-
binding C domain (DBD) and ligand-binding E domain 
(LBD) are essential for the NR activity and both display 
a higher level of conservation than the AB domain. In 
all the NR, C domain has a characteristic DNA-binding 
structure of zinc fingers. Between C, and E domains, 
there is a short fragment D, playing the role of an elastic 
linker. E domain has a ligand-binding site and it recruits 
transcription coactivators, which makes it the main tar-
get of the pharmaceutical research; moreover, in most 
receptors, E domain is responsible for dimerization [30].
Many nuclear receptors exist in isoforms due to alterna-
tive splicing and the presence of alternative translation 
initiation sites. Understanding the function of specific 
protein variants is very important in relation to tissue-
specific glucocorticoid receptors actions. It is known 
that in specific tissues different kinds of MR and GR iso-
forms are expressed. Isoforms may be elements of vari-
ous pathways, which makes the biology of GR and MR 
particularly complex. 
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ENDOGENOUS LIGANDS OF GLUCOCORTICOID AND 
MINERALOCORTICOID RECEPTORS
The main endogenous ligands of glucocorticoid receptors 
are aldosterone (for MR) and glucocorticosteroids: cortisol/
corticosterone (for GR and MR). Endogenous glucocorticos-
teroids (cortisol, corticosterone) have a broad spectrum of 
action. They are involved in the functioning of almost all 
cells, and it is estimated that they directly or indirectly reg-
ulate the activity of 10% of human genes [7]. The distribu-
tion of MR and GR in an organism reflects the physiological 
role of their ligands [27, 60, 69].
Aldosterone controls the expression of genes involved 
in the regulation of water and salt balance in the organ-
ism. Its major role is to upregulate the renal sodium 
reabsorption and to induce the release of potassium and 
hydrogen ions into renal collecting tubules. Further-
more, aldosterone receptors MR are found in organs 
such as kidneys, sweat glands, salivary glands, and colon. 
By regulating water balance, MR also affect blood pres-
sure, thus expressed also in the heart cells [25]. MR are 
also located in the brain, primarily in the hippocampus, 
where their ligands are glucocorticosteroids. Glucocor-
ticoid receptors GR are located in almost all cells of the 
GR-coding gene, similarly to MR-coding gene, contains 
9 exons. As a result of alternative splicing of a precursor 
mRNA, 5 subtypes of the GR receptor (GRα, GRβ, GRγ, 
GR-A and GR-P) and 3 MR receptor subtypes (MRα, MRβ 
and MRγ) may be synthesized. Isoforms perform dif-
ferent functions. For example, GRβ variant is shorter 
from GRα by the last 15 amino acids and it is unable to 
bind cortisol. However, it is constitutively expressed 
in the nucleus and can regulate transcription of spe-
cific genes [61, 74]. Additionally, particular isoforms are 
expressed during various pathological processes. For 
instance, reduced temperature during ischemia causes 
the increase of MRβ isoform transcription, which pro-
motes neuronal survival [33].
MR and GR receptors form a complex with chaperone pro-
teins HSP (heat shock proteins) family, HSP90 and HSP70. 
These proteins stabilize the receptors and decrease their 
affinity to DNA. Upon ligand binding, HSP dissociate from 
MR/GR, which exposes the DNA-binding domain [26, 35, 
59]. Most are localized in the nucleus, however, the inac-
tive MR and GR are present in the cytoplasm. The bind-
ing of the ligand and subsequent HSP dissociation exposes 
nuclear localization signals, which leads to translocation of 
the receptors to the nucleus [62] (Fig. 1).
Fig. 1. The structure of glucocorticoid and mineralocorticoid receptors (adapted from [6])
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energy demand during stress. They also regulate the 
immune response, and their role in immunosuppres-
sion has been used in pharmacology for many years.
Glucocorticosteroids also play an important role in the 
development of the central nervous system and in brain 
plasticity processes in adulthood. Glucocorticosteroid-
induced increase in the hippocampal levels of brain-
derived neurotrophic factor (BDNF) after exposure to 
stress seems to be a basic neuroadaptive mechanism 
that determines adaptation of an organism to new con-
ditions [10, 21].
THE PHYSIOLOGICAL ROLE OF GLUCOCORTICOID AND 
MINERALOCORTICOID RECEPTORS
Due to the structural similarity of steroids and homol-
ogous structures of their receptors, MR and GR do not 
bind exclusively to one type of ligand. MR have the same 
affinity for aldosterone as for glucocorticosteroids [22]. 
Furthermore, contrary to the adopted nomenclature, 
MR has a 10-fold greater affinity to than GR. Biochemi-
cally MR is the primary glucocorticoid receptor, which 
has significant physiological consequences [42, 65].
Glucocorticosteroids, circulating in the blood at 100 
times higher concentration than aldosterone, compete 
with it for the active site of MR, which are located in 
the cells of organs responsible for fluid and electrolyte 
balance. In the cytoplasm of these cells an enzyme 11-β 
hydroxysteroid dehydrogenase 2 (HSD11β2) is present. 
It inactivates cortisol and corticosterone by oxidiz-
ing it to inactive cortisone and 11-deoxycorticosterone 
respectively. In the absence of active glucocorticos-
teroids, MR bind aldosterone. Another isoform of this 
body. Particularly high density of GR is observed in the 
hypothalamic paraventricular and supraoptic nuclei and 
in pituitary corticotropic cells, where they play a cen-
tral role in the regulation of the hypothalamo-pituitary-
adrenal [23, 29, 34].
The main function of glucocorticosteroids is to man-
age the broadly understood stress response, and their 
release depends on the activity of the hypothalamo-
pituitary-adrenal axis. HPA axis is one of the neuro-
hormonal systems associated with the stress response. 
Corticoliberin (CRH), which is synthesized in the para-
ventricular nucleus of the hypothalamus, stimulates the 
pituitary gland to secrete the adrenocorticotropic hor-
mone (ACTH). This hormone stimulates the cells of the 
adrenal cortical layer to synthesize glucocorticosteroids. 
The stress stimuli increase the secretion of the glucocor-
ticosteroids into the blood [13, 29, 42, 65].
Corticosterone prevents excessive stimulation of the HPA 
axis due to negative feedback at the level of the pituitary, 
hypothalamus and hippocampus [13, 31]. Such regulation 
of the body’s stress response is possible due to the inter-
action of corticosterone with steroid receptors: mineralo-
corticoid (MR) and glucocorticoid (GR), which are highly 
expressed in the hippocampus. The corticosteroid release 
may largely depend on the activity of mineralocorticoid 
receptors, whose inhibitory role in modulating the basic 
activity of the HPA axis [13].
In addition, due to the important role of glucocorticos-
teroids regulation, high concentrations of GR are found 
in the liver and adipose tissue. These hormones control 
the energy metabolism by stimulating the catabolism 
of carbohydrates and proteins in response to greater 
Table 1. Comparison of selected properties of glucocorticoid (GR) and mineralocorticoid (MR) receptors
GLUCOCORTICOID
RECEPTOR
MINERALOCORTICOID
RECEPTOR
Ligand
cortisol
corticosterone
cortisol
corticosterone
aldosterone
Antagonist
mifepristone (non-specific)
RU-43044
spironolactone
RU-28318
Cortisol/corticosterone
affinity
low high
Localization
all cell types
particularly high density in the HPA axis structures 
kidneys
heart
sweat glands
limbic system: hippocampus
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after a stroke to prevent inflammation increase brain 
damage [16]. Similar effects of glucocorticosteroids are 
also visible in elderly people suffering from atherosclero-
sis. Atherosclerosis impairs the flow of blood in the brain, 
which causes its hypoxia. In a stressful situation, e.g. dur-
ing hospitalization, in people with atherosclerosis an addi-
tional release of cortisol results in a rapid impairment of 
the hippocampus function and related memory disorders 
and disorientation [47].
To fully understand the role of glucocorticoid recep-
tors in the pathophysiology of hypoxia, it is necessary 
to outline the changes occurring in neurons under con-
ditions of pathological oxygen depletion. Oxygen or 
glucose deficiency leads very quickly to the inhibition 
of ATP resynthesis in cells. The maintenance of resting 
cell potential depends on the action of ATP-depend-
ent ion pumps. ATP in neurons is mainly used to oper-
ate the sodium potassium pumps in order to maintain 
the resting potential and for repolarization after the 
action potential. In the absence of ATP, rapid cell depo-
larization occurs. This is related to the opening of volt-
age gated ion channels, including calcium channels. An 
uncontrolled Ca2 + influx causes the release of glutamate, 
the main excitatory neurotransmitter in the central 
nervous system. Due to the lack of ATP, the reuptake of 
this amino acid from the synaptic cleft is disturbed. Glu-
tamate activates ionotropic glutamate receptors: NMDA 
and AMPA, additionally enhancing the influx of Ca2+, Na+ 
and Cl- to the cell. Glutamate also binds to metabotropic 
glutamate receptors, which, by activating phospholipase 
C, triggers calcium release from intracellular compart-
ments. Simultaneously, along with the Na+ and Cl- ions, 
water flows passively into the cell causing its exten-
sive swelling and inflicting mechanical damage on the 
cell [17, 54, 57, 66]. Overloading the cell with calcium, 
which acts as a second messenger, causes the activation 
of proteolytic enzymes and phospholipases that damage 
the cell membrane. Furthermore, excessive activation 
of such enzymes as cyclooxygenase or neuronal nitric 
oxide synthase causes the formation of reactive oxy-
gen species. If the cell does not undergo a rapid process 
necrosis, it can enter the intrinsic apoptotic pathway [9].
Apoptosis is programmed cell death – a strictly controlled 
process aimed at eliminating damaged, defective or super-
numerary cells. For this reason, this process is particularly 
important during development, growth and regenera-
tion, as well as in the body’s response to pathological stim-
uli [18, 58]. Apoptosis is contrasted with necrosis, in which 
the severity of cellular damage precludes apoptotic reac-
tions. Apoptosis can be distinguished from necrosis based 
on a microscopic image of a dying cell as well as molecular 
markers characteristic for these processes. During apop-
tosis, the integrity of the cell membrane is not disturbed, 
so that the cytoplasm does not escape into the intercel-
lular milieu. The cell is fragmented into the so-called 
apoptotic bodies that are subsequently phagocytosed by 
macrophages. In the case of necrosis, the cell is unable to 
maintain its membrane potential and proper osmotic pres-
enzyme (HSD11β1) is present in cells responsive to glu-
cocorticosteroids. This enzyme reverses the inactivating 
reaction and converts cortisone and 11-deoxycorticos-
terone to, respectively, corticosterone or cortisol [42, 
75]. HSD11β1 is present in the brain, and particularly 
high concentrations are observed in the hippocampus, 
the paraventricular nucleus of the hypothalamus and 
in the anterior pituitary gland. This suggests that this 
enzyme affects the level of glucocorticosteroids in the 
structures important for HPA axis regulation. It has been 
confirmed by studies on HSD11β1 -/- knockout mice, in 
which abnormal HPA axis activity is observed [28].
The high affinity of MR to glucocorticosteroids makes 
these receptors activated already at low level of corti-
sol in the blood. Activation of GR occurs, however, with 
increased hormone concentration, e.g. before waking 
up (in a natural circadian rhythm) and during the stress 
response. In neurons, activation of MR or GR mainly 
affects transport of ions through the membrane and 
the levels of produced neurotransmitters. As transcrip-
tion factors, these receptors primarily trigger a genomic 
response, although their more rapid, non-genomic action 
is also observed [42]. This type of action (mainly per-
formed by MR) in response to acute stress manifests itself 
in the facilitated release of glutamate to the synaptic 
cleft, changes in post-synaptic potassium currents and in 
enhancing long-term potentiation (LTP), which is a mech-
anism important in learning processes [32, 53].
Modulation of the genomic response involving MR and 
GR is remarkably complex. Based on the analysis of pal-
indromic sequences of promoter elements recognized by 
these transcription factors (including hormone response 
element, HRE), it has been concluded that after ligand 
binding, they dimerize and in this form bind to the cor-
responding DNA fragment. Studies have shown that in 
addition to the formation of homodimers (GR-GR), GR 
may form with MR. Regulation and the role of heter-
odimerization has not been fully explained, but it has 
been recently demonstrated that during acute stress, 
heterodimers bind to different promoters than homodi-
mers, which suggests their important role in the stress 
response [52, 72]. Furthermore, monomers can regulate 
the activity of other transcription factors or act repres-
sively by blocking the site for the activating dimer (Fig-
ure 2). Some splicing variants of GR and MR, which have 
no ability to bind the ligand but bind to the specific reg-
ulatory of DNA, may work in a similar manner [13, 59].
THE ROLE OF GLUCOCORTICOID RECEPTORS IN HYPOXIA
The neuroprotective and neurodegenerative role of gluco-
corticosteroids and their receptors becomes particularly 
significant in neurological crises, such as brain hypoxia/
ischemia. During the neurological crisis, the body’s natu-
ral response is to increase the blood glucocorticosteroid 
levels. One of the first indications that glucocorticoster-
oids may potentiate the damaging effects of hypoxia was 
the observation that glucocorticosteroids administered 
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Brain development during embryogenesis involves the 
removal of supernumerary neurons via precisely con-
trolled apoptosis. It is estimated that over half of the 
neurons are removed in this way during the develop-
ment. The control of apoptosis must also be maintained 
in the mature brain. In most brain structures neurogen-
esis ceases immediately after birth and neurons must 
perform their function until the end of the individual’s 
life. In consequence, neurons must be equipped with 
preventive mechanisms to avoid accidental activation of 
the apoptotic pathway [37, 43].
Necrotic cell death results in the release of cellular con-
tents, including proteolytic enzymes and excitotoxic 
glutamate, into the extracellular space, which damages 
neighbouring cells. Cells in the hypoxic core undergo 
necrosis and this process is very rapid and irreversible. 
However, around this area, cells maintain integrity. This 
is the, so-called, penumbral region where neurons can 
enter the apoptotic pathway. Much depends on the type 
and duration of hypoxia, the type of neuron, the stage of 
the cell cycle, the amount of available ATP (indispensable 
to create a functional apoptosome and to synthesize regu-
latory proteins) at the time of neurological crisis and the 
condition of neighbouring cells. In the penumbral area, 
the process of apoptosis is relatively long-lasting, even up 
to a week after the episode of hypoxia [44].
The brain area that is particularly vulnerable to hypoxia-
induced damage is the hippocampus. The hippocampus 
is a part of the vertebrate limbic system responsible for 
memory consolidation and spatial orientation. It forms 
numerous connections with other brain regions, mainly 
sure; it swells and breaks, which usually involves damage to 
the neighbouring cells and the emergence of inflammation. 
It is believed that there is no distinctive boundary between 
necrosis and apoptosis, and the observed processes are a 
continuum, rather than a dichotomy (currently including 
the necroptosis process, among others) [15, 18].
There are two main apoptotic pathways: extrinsic and 
intrinsic. The extrinsic one is based on the signalling 
pathway triggered by the activation of membrane recep-
tors, including TNF (tumor necrosis factor) receptors. 
Hypoxia-induced neuronal apoptosis is activated mainly 
by the intrinsic pathway [56]. The intrinsic pathway is 
controlled by the bcl-2 family of proteins. Almost all 
human cells maintain a constant level of these proteins, 
especially of the proapoptotic: Bax and Bak and antia-
poptotic: Bcl-2 and Bcl-XL. Concentration ratio between the two types of proteins determine the cell fate and is 
one of the apoptotic markers. Bcl-2 proteins are located 
in the outer mitochondrial membrane and modulate its 
permeability. The main element of the apoptotic pro-
cess is the activation of Bax protein which, by the forma-
tion of channels in the outer mitochondrial membrane, 
causes the release of cytochrome c from the mitochon-
drial intermembrane space. Bax protein regulates p53 
protein, which controls numerous processes in the cell 
and is a part of signalling pathways associated with DNA 
repair and apoptosis [55]. Further stages of apoptosis are 
mediated by proteases from the caspase family [51].
The intrinsic pathway in neurons is similar to that in 
other types of cells, but the regulation of proteins asso-
ciated with the apoptotic pathway is more stringent. 
Fig. 2. Mechanisms of regulation of gene expression by glucocorticosteroid receptors: GR and MR; A – typically, the receptors homodimerize after ligand binding. The 
homodimer binds to the HRE sequence and activates (+) or represses (-) the transcription of a particular gene. B – in the indirect regulation mechanism, ligand-activated 
monomers modulate the activity of other transcription factors (TFs). C – regulation of transcription through heterodimerization (MR with GR) is the least-studied 
mechanism. It is suggested that heterodimerization may lead not only to the connection with HRE, but also to previously unknown regulatory sections (adapted from [13])
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limits the activation of GR and reduces excitotoxic neu-
ronal damage [63]. Active GR presumably interact with 
different hypoxia-response genes or with stimuli modu-
lating this response (e.g. HIF-1), for example affecting 
the distribution of glucose transporters, crucial in the 
energy crisis (Figure 3) [36, 65]. However, it seems that 
the neurotoxic action of GR is manifested, above all, in 
the induction of apoptosis [2], which is why this issue 
requires a separate discussion.
NEUROPROTECTIVE ROLE OF MINERALOCORTICOID 
RECEPTORS DURING HYPOXIA 
The occurrence of GR in the hippocampus is relatively easy 
to explain, because it is the primary regulatory centre of 
HPA axis activity. But what is the reason for the presence 
of aldosterone receptors (MR) in this area, a hormone that 
regulates the body’s water and mineral balance?
Previous studies have shown that the synthesis and acti-
vation of MR during the influence of various types of 
stressors raise the chance of neuronal survival, suggest-
ing that it presents an adaptive mechanism, activated 
in response to damage. An increase in the synthesis of 
MR receptors was found in CA1 region of the hippocam-
pus, where ischemia-induced cell damage occurred [31]. 
Moreover, it was shown that shifting the balance 
towards increased MR activity after inhibiting GR recep-
tors protects neurons from damage under ischemic con-
ditions [38]. Elevated MR concentration is also observed 
in fragments of the hippocampus collected post mortem 
from people who died due to a cardiac arrest [40].
Animal studies with MR gene deletion or after ADX 
suggest that MR perform an important function in the 
proliferation of neurons in the dentate gyrus and also 
indicate the neuroprotective role of these receptors 
in CA1-CA4 regions of the hippocampus  [45]. More-
over, it was found that concentrations of corticos-
terone specifically activating MR promote neuronal 
survival  [2]. Staurosporine is a compound used for 
the experimental induction of apoptosis. However, it 
occurs that the administration of small doses of stau-
rosporine has a neuroprotective effect. This is most 
likely associated with MR activation, because blocking 
these receptors with selective antagonists – spironol-
actone or RU28318 – inhibits the neuroprotective effect 
of staurosporine. Increasing number of studies shows 
a natural rise in MR concentration in response to stau-
rosporine-induced and aging- or hypoxia-related apop-
tosis of hippocampal cells [33]. Particularly pronounced 
changes in MR expression are observed in neurons of 
rats exposed to hypoxia/ischemia under thermal stress 
conditions (hypothermia and hyperthermia) [33, 45, 68].
In order to develop effective therapies based on the 
properties of the described receptors, it is crucial to 
elucidate the mechanism of MR activity. There are 
no detailed, molecular studies focusing on processes 
occurring in the hypoxic cell after MR activation, how-
with the prefrontal cortex, and also plays a superior role 
in controlling the activity of HPA axis. Four main anatom-
ical areas are distinguished in the hippocampus: CA1, CA2, 
CA3 regions comprised of pyramidal neurons and dentate 
gyrus (DG) consisting of granular neurons. The dentate 
gyrus is one of the only brain regions where neurogen-
esis occurs also in mature mammals, i.e. after the devel-
opment of the central nervous system is complete [14]. 
Both types of glucocorticosteroid-binding receptors (MR 
and GR) are highly expressed in the hippocampus, which 
makes this area of the brain the main target of glucocor-
ticosteroids [13, 65]. Excessive, as well as too low concen-
trations of glucocorticosteroids increase the vulnerability 
of the hippocampus to the damage induced by excitotox-
icity, oxidative stress or hypoxia/ischemia [71].
ACTIVATION OF GR RECEPTORS AND NEURODEGENERATION
GR are activated when the level of glucocorticosteroids 
increases, which occurs during the peak of endocrine 
secretion or after exposure to a stress stimulus [13, 32, 
50]. Stress induces the release of stress response hor-
mones regardless of the type of stress factor. Hypoxia/
ischaemia is one of such stimuli  [67]. The role of 
enhanced GR activity in the increase of vulnerability of 
hippocampal cells to excitotoxic or hypoxic/ischemic 
damage has been confirmed by numerous studies [50, 
70, 71]. The administration of specific GR agonists 
(methylprednisolone and dexamethasone) contributes 
to the increased damage of nerve cells [2, 73]. Therefore, 
it is believed that the neurotoxic effects of elevated glu-
cocorticosteroid levels are mediated by glucocorticoid 
receptors [13], which are activated at high concentra-
tions of these hormones.
The cascade of pathological events under hypoxia 
begins with an energy crisis which is supposed to be 
counteracted by the stress hormones and the influx of 
glucose to the regions of the body that are most mobi-
lized under stress conditions, including the brain. How-
ever, with a prolonged (over 30 minutes) exposure to 
stress hormones, especially to glucocorticosteroids, 
some cells, such as hippocampal neurons, are affected 
by a significant fall of glucose level. In the course of 
hypoxia there is often a synergistic effect of two stim-
uli: the lack of oxygen and the excessive activation 
of GR, which cause a decrease in the level of glucose. 
Exposing hypoxic rats to stress enhances brain dam-
age. This happens when the stress-induced elevated 
concentration of corticosterone intensifies the energy 
crisis in neurons [1]. The simultaneous activation of GR 
and exposure to hypoxia aggravate the brain damage 
by activating specific pathological processes.
The harmful effects of GR activation under hypoxic con-
ditions are confirmed by studies in which reduction of 
post-ischemic damage occurs after administration of GR 
antagonist RU486 or after adrenalectomy [50, 71]. It has 
also been demonstrated that administration of HSD11β1 
inhibitors reduces the level of corticosterone, therefore 
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Adrenalectomized rats (ADX; surgical removal of the 
adrenal glands – the natural source of glucocorticoster-
oids) have changed expression profiles of Bax, Bcl-2, and 
Bcl-XL in various areas of the hippocampus after corticos-terone administration. In the dentate gyrus (DG), i.e. in 
the area where neuronal proliferation continues, the con-
centrations of bcl-2 proteins change after adrenalectomy. 
Additionally, increased production of Bax is observed, 
which returns to the baseline level after administration of 
an exogenous hormone dose, capable of full MR and only 
partial GR activation. This may indicate that Bax expres-
sion or p53 protein activity [8]. However, there are also 
studies that showed that selective MR blockage does not 
contribute to the changes in the level of apoptosis-con-
trolling proteins, and it is rather GR that determine the 
fate of granular cells in DG [45].
The cells of CA1, CA2 and CA3 regions of the hippocam-
pus appear to respond differently to ADX. ADX-induced 
reduction of corticosterone level causes an increase in 
anti-apoptotic Bcl-2 protein concentration. The same 
can be applied to the DG described above, except that in 
CA areas, especially CA1, there is a marked decrease in 
Bcl-2 level after corticosterone administration. This may 
indicate a negative regulation of Bcl-2 expression by glu-
cocorticoid receptors in CA1 region. Simultaneously, it 
appears that administration of small doses of corticos-
terone (activating only MR) in drinking water, promotes 
the expression of Bcl-2 in CA1 and CA3 [8]. However, it 
should be emphasized that unequivocal conclusions 
regarding the role of receptors in the survival of hip-
pocampal cells cannot be made only on the basis of stud-
ies in which hormone levels were manipulated.
In young (3 month-old) and old (24 month-old) rats, sig-
nificant differences were demonstrated in the apoptotic 
coefficient (number of cells undergoing apoptosis per 
10.000 intact cells) depending on the activation of spe-
cific receptors [2]. To determine the effects caused by a 
particular receptor, one of the rat groups was given corti-
costerone at the concentration mainly activating MR, and 
the other was administered a selective GR ligand – dexa-
methasone (DEX; synthetic glucocorticosteroid). Adminis-
tration of corticosterone caused a decrease in the value of 
apoptotic coefficient in old rats. In contrast, DEX admin-
istration caused an increase in this coefficient in both 
groups, but in older rats, enhanced neurodegeneration 
due to selective GR activation was observed. Analysis by 
in situ hybridization showed changes in the mRNA level 
of all bcl-2 family proteins. However, it was the effect of 
selective MR activation on the level of pro-apoptotic Bax 
protein that was the most remarkable. MR activation sig-
nificantly reduced Bax concentration in the dentate gyrus 
cells, whereas GR activation increased the concentration 
of Bax proteins. The positive regulation of Bax expression 
by selective GR activation may also be evidenced by the 
fact that Bax -/- mice do not exhibit increased apopto-
sis after DEX administration. The action of the hormone 
by MR stimulates the synthesis of Bcl-2 in old rats, which 
enhances neuroprotection [2].
ever, the available data suggest several hypotheti-
cal mechanisms. Binding of the ligand to the receptor 
releases the associated HSP proteins as well as immu-
nophilins. Proteins from the HSP family perform a 
number of functions related to stress response, includ-
ing regulation of apoptotic processes [5]. In contrast, 
immunophilins, which are involved in axonal transport 
and the formation of synaptic vesicles, prevent protein 
aggregation, which is one of the basic processes in the 
course of neurodegeneration [4] (Figure 3). Elevating 
of the concentration of free forms of chaperone pro-
teins may contribute to neuronal protection, however, 
it should be borne in mind that the same proteins are 
associated with GR, the activation of which induces 
neurodegenerative processes.
Because MR and GR have an adverse effect on cells 
under specific conditions, it is suggested that the ratio 
of their concentrations is significant for the survival of 
the neuron. Increased MR concentration, in response to 
hypoxia, may indirectly prevent excessive GR activation. 
It is also indicated that GR and MR expression is depend-
ent on the concentration of active forms of these recep-
tors, e.g. an increase in GR concentration is observed 
with selective blocking of MR [12].
As mentioned earlier, the effect of glucocorticosteroids 
via GR enhances the excitotoxicity by over-activation 
of glutamate receptors. On the contrary, MR are able 
to inhibit the transcription of subunits of some types 
of calcium channels and NMDA receptors [32, 65]. The 
reduction in the number of calcium channels and NMDA 
receptors activity reduces the influx of calcium ions, 
which may be crucial reducing the excitotoxic effect 
implicated by GR activation under hypoxic conditions. 
However, the most important potential neuroprotective 
mechanism mediated by MR is their effect on the of anti-
apoptotic Bcl-2 and Bcl-XL proteins [2].
THE ROLE OF GLUCOCORTICOSTEROIDS AND THEIR 
RECEPTORS IN NEURONAL APOPTOSIS 
The most important role of GR and MR in determining 
neuronal fate after hypoxia/ischemia is their pro- and 
antiapoptotic effect dependent on the concentration of 
glucocorticosteroids [32] (Figure 3). The completion of 
nervous system development is associated with a rapid 
decline in the anti-apoptotic Bcl-2 protein level, consti-
tuting natural end of neurogenesis. Due to the specificity 
of the dentate gyrus, the concentration of this protein in 
the granular DG cells remains unaltered, which presum-
ably sustains neurogenesis in this brain region. Simul-
taneously, stable, relatively low levels of proapoptotic 
proteins are observed in other areas of the brain [43]. 
In the dentate gyrus, the ratio of pro- and antiapoptotic 
protein concentrations determines the cell fate, and 
therefore experimental studies in which the pro- and 
antiapoptotic balance is modified allow the role of GR in 
the apoptosis to be investigated.
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multiple levels of the cascade of events under hypoxia/
ischemia. There are numerous possibilities: inhibition 
(administration of antagonists) of glutamate receptors, 
scavenging of free radicals, inhibition of proteins regu-
lating the apoptotic or inhibition of inflammation [19, 
54]. Studies on the role of MR and GR in the pathophysi-
ology of hypoxia indicate that they may also be a poten-
tial drug target. The presented state of knowledge on 
the role of glucocorticoid receptors in the pathophysi-
ology of brain damage and their impact on the fate of 
neurons indicate the scale of the challenge that scien-
tists face. The results of the research reveal the network 
of interactions within the cell, between cells and the 
organism and the environment, which should be taken 
into account when developing new therapies.
Considering the current state of knowledge regard-
ing these receptors, it seems that their activity could 
both prevent the occurrence of brain damage, as well 
as eliminate the effects of already existing changes. A 
research review on the role of MR and GR receptors in 
the pathophysiology of hypoxia indicates that their 
activity is of a dose-dependent (hormetic) nature. 
Hormesis is a bidirectional reaction of an organism to 
a dose, which stimulates the organism in the range of 
small doses of the environmental factor and inhibits 
its vital functions at high doses [48]. Only in the case 
of a specific (usually low) range of a given parameter 
(concentration and time of exposure to the hormone) 
Moreover, studies have shown a significant increase in 
the concentration of pro-apoptotic p53 protein after dex-
amethasone administration, which was not observed in 
the case of corticosterone administration, suggesting that 
selective GR activation and increased p53 expression are 
related [65]. However, it is uncertain whether activation of 
GR and increased expression of p53 cause apoptosis in all 
cells, because it has been demonstrated that hippocampal 
DG neurons do not undergo cell death. Instead, their cell 
cycle stops in the G1 phase, which means that neuronal 
proliferation, characteristic this brain region, is inhib-
ited [12]. The involvement of MR in the regulation of p53 
expression has also been shown [2, 49]. It is also worth not-
ing that the blockage of MR with spironolactone reduces 
the level of mRNA for the Bcl-2 protein [49], suggesting 
that activation of MR receptors determines the expression 
of anti-apoptotic Bcl-2 protein and may affect the survival 
of neurons after injury. This phenomenon may be of fun-
damental importance for inhibiting the delayed neuronal 
death due to hypoxia/ischemia. Importantly, it seems that 
the ratio of pro- and antiapoptotic protein concentrations 
results from different levels of activation of the glucocorti-
coid receptors being discussed [12].
CONCLUSION
Understanding the complexity of neurodegenerative 
processes is an enormous challenge for clinicians, but 
it is essential to develop therapies that are effective at 
Fig. 3. Scheme of apoptosis regulation through glucocorticosteroid receptors. MR and GR antagonistically activate and inhibit gene expression for proteins regulating 
the process of apoptosis (arrow with pointed arrowhead and without it mean respectively: positive and negative regulation of the expression)
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ate neuroadaptive processes, whereas large doses of 
corticosterone activate GR and thus, stimulate neuro-
degeneration [1, 32, 65].
The dichotomous effect of glucocorticoid receptors on the 
survival of neurons can be applied in the development of 
new therapeutic strategies. The results of the cited stud-
ies indicate the interactions of MR and GR with apoptosis-
controlling proteins and thus point to new directions in 
designing drugs specifically targeted at cells undergoing 
apoptosis as a result of hypoxia/ischemia.
an organism is able to maintain homeostasis. Short-
term, elevated concentration of glucocorticosteroids 
is a signal in the physiological norm for an organism 
and performs an adaptive function. However, chronic 
exposure to glucocorticosteroids leads to numer-
ous negative consequences  [24]. With their endur-
ing elevated level, e.g. in the Cushing’s syndrome, 
when some steroid drugs are administered or when 
chronic stress occurs, the hippocampus functions 
are disturbed, mainly due to GR hyperactivity  [70]. 
Small doses of the hormone activate MR that medi-
Fig. 4. Summary of the main processes in the pathophysiology of hypoxia in which the regulatory influence of GR and MR receptors was confirmed
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